Loading...
Hims & Hers Health Inc. ($HIMS) is set to outperform expectations in 4Q23 with revenue estimates of $243-248 million, significantly higher than the forecasted $228 million. The company's EBITDA is also expected to exceed the estimated $10.5 million, with a projection of $14-17 million. Alongside these positive forecasts, the company has announced a $50 million share buyback program. On the other hand, CNH Industrial, a prominent player in the farm and construction equipment market, has announced a $1 billion share buyback program to facilitate its single-listing on the NYSE.
CNH launches $1 bln buyback to support NYSE single listing plan https://t.co/0BLxPzGcZv https://t.co/1XRwZowCsy
CNHI listing on NYSE as only mkt Announced major buyback
CNHI(Case New Holland). Listing on NYSE. Also major buyback announced
〽️ CNH LAUNCHES $1 BILLION BUYBACK TO SUPPORT NYSE SINGLE LISTING PLAN Farm and construction equipment maker CNH Industrial said on Tuesday it had approved a new share buyback program worth up to $1 billion as part of its plan to pursue single-listing in New York. https://t.co/im5Vw3UKL6
$HIMS sees 4q23: Revenue at $243-248mn, est 228mn Ebitda at $14-17mn vs est 10.5mn Announces $50mn buyback vs $1.3bn mkt cap